Over the past two decades, oncology has undergone a profound transformation, largely driven by the rise of targeted therapies and immune-modulating agents. By tailoring treatments to the molecular pro...

AbstractBackground. Improved prognostic stratification including imaging-based parameters is needed to guide treatment decisions in IDH-mutant glioma.Metho

YouTube video by Ludwig Boltzmann Gesellschaft

Registration for the NMN Symposium 2025 is OPEN! Regsitration Fees Early Fee* until February 28, 2025 Late Fee until May 05, 2025 Onsite Fee May

Purpose High-grade meningiomas have high recurrence rates and limited prognosis. Radioligand therapies are approved in extracranial malignancies, but their value in brain tumours including meningiomas...

AbstractBackground. Recently, criteria based on amino acid positron emission tomography (PET) have been proposed for response assessment in diffuse gliomas

This joint practice guideline/procedure standard was collaboratively developed by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), th...